This quarter brings a significant range of developments across both Irish and EU frameworks:
- Central Bank developments across tokenisation, prohibition notice procedures and its Regulatory and Supervisory Outlook for the year ahead.
- Streamlined procedures for AIFMD II / CP161 162 filings for existing Irish UCITS and AIFs, as well as for AIFMs performing loan origination and the finalisation of EU liquidity management rules.
- Wider EU reforms across EMIR 3, venture and growth capital funds, benchmarks regulation and sustainability reporting.
- Key dates for 2026 - 2027, covering AIFMD II, ESG ratings, the EU single AML rulebook and the move to T+1 settlement.